Related Articles
PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA - TREATMENT WITH MULTIAGENT SYSTEMIC AND INTRATHECAL CHEMOTHERAPY WITH RADIATION-THERAPY
Quality of life three months post‑stroke among stroke patients and their caregivers in a single center study from Romania during the COVID‑19 pandemic: A prospective study
Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
Management of refractory or relapsed primary central nervous system lymphoma (Review)
Combined quality of life and posttraumatic growth evaluation during follow‑up care of patients suffering from oral squamous cell carcinoma